Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model. (2018)

First Author: Pashayan N

Attributed to: FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.25762

Publication URI: https://www.repository.cam.ac.uk/handle/1810/278416

Type: Journal Article/Review